Swedish Orphan Biovitrum AB(DE:B6E)
€44.04+-1.96 (+0.41%)
DE:B6E
Swedish Orphan Biovitrum AB financials statements
€44.04
At close:+-1.96 (+0.41%)
Swedish Orphan Biovitrum AB (B6E) Income Statement
5 Followers
Swedish Orphan Biovitrum AB Income Statement
Last quarter (Q3 2026), Swedish Orphan Biovitrum AB's total revenue was kr9.12B, an increase of 17.34% from the same quarter last year. In Q3, Swedish Orphan Biovitrum AB's net income was kr2.35B. See Swedish Orphan Biovitrum AB’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| kr 28.24B | kr 26.03B | kr 22.12B | kr 18.79B | kr 15.53B | |
| kr 12.32B | kr 20.24B | kr 9.95B | kr 13.98B | kr 12.04B | |
| kr 4.27B | kr 14.62B | kr 5.88B | kr 10.17B | kr 8.26B | |
| Depreciation and Amortization | kr 10.10B | kr 3.68B | kr 3.17B | kr 2.27B | kr 2.01B |
| kr 10.96B | kr 9.30B | kr 7.23B | kr 6.05B | kr 5.72B | |
| kr 8.05B | kr 5.63B | kr 4.07B | kr 3.81B | kr 3.73B | |
| kr -8.01B | kr -1.22B | kr -1.11B | kr -492.00M | kr -438.00M | |
| kr 34.00M | kr 4.41B | kr 2.95B | kr 3.32B | kr 3.29B | |
| kr 478.00M | kr 3.88B | kr 2.41B | kr 2.64B | kr 2.68B | |
| Per Share Metrics | |||||
| Basic EPS | kr 1.39 | kr 11.37 | kr 7.47 | kr 8.52 | kr 8.67 |
| Diluted EPS | kr 1.37 | kr 11.24 | kr 7.39 | kr 8.44 | kr 8.62 |
| Weighted Average Shares Outstanding | 344.30M | 341.73M | 322.66M | 309.48M | 308.90M |
| Weighted Average Shares Outstanding (Diluted) | 347.61M | 345.56M | 325.97M | 312.46M | 310.73M |
Currency in SEK
